MedPath

RUZURGI

RUZURGI

Approved
DIN Number

02503034

Drug Class

Human

Market Date

Sep 24, 2020

Company
HC

medunik canada

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02503034
AIG Number0162417001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N07XX05 AMIFAMPRIDINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:92.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

AMIFAMPRIDINEActive
Strength: 10 MG
Monograph: AMIFAMPRIDINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.